The role of regulated clinical trials in the development of bacteriophage therapeutics.
about
Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Adapting Drug Approval Pathways for Bacteriophage-Based TherapeuticsQuality and safety requirements for sustainable phage therapy products.Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirsWhat are the limitations on the wider therapeutic use of phage?In vitro Effectiveness of Commercial Bacteriophage Cocktails on Diverse Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains.Call for a dedicated European legal framework for bacteriophage therapy.Novel avenues for Clostridium difficile infection drug discovery.Phage therapy: eco-physiological pharmacology.Phage approved in food, why not as a therapeutic?Bacteriophage therapy: a regulatory perspective.Phage Therapy: Future Inquiries.Paenibacillus larvae-Directed Bacteriophage HB10c2 and Its Application in American Foulbrood-Affected Honey Bee Larvae.Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework.Complete genome sequence of Bp7, an Escherichia coli bacteriophage with a wide host range.Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water.Bacteriophages and Biofilms.Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.Bacteriophage Therapy: Clinical Trials and Regulatory HurdlesRebuilding the Gut Microbiota Ecosystem
P2860
Q24563742-A614E31B-1A65-4658-946E-40B9389A03DCQ26740597-4BA28082-6B8A-4965-A4BB-0883AC031799Q35674419-4B668A10-5466-4678-9F7F-CC67C8778CA9Q36910633-7F2C624D-10A3-46E3-BA24-915524108FBFQ37291441-3503E5EB-5F18-4E9A-9C90-D6E204CB42F7Q37389468-D689E20D-DE5B-48D5-B433-D687AF7C356AQ37631618-EC189C97-0622-4161-B11E-D89CDC2F6672Q38083297-96E247E3-19A1-4200-89B7-E8AB93B7F82AQ38230407-F76CA5AB-E89C-4D98-A19D-97064EA29849Q38285489-E000C498-8187-4DF6-983C-7394F2CC4509Q38805538-4FD6BB7F-61B2-4928-B22E-425F944EC9DBQ38911928-08D0FC56-3BD7-40D4-B9F7-079F890232B3Q38998688-1EFCDB05-A57A-4C05-BD2D-044827EDBDCDQ40173306-4C5893A8-6BE2-407F-93BA-4064267BD978Q40867366-2F434D5D-9928-42D3-887C-F677AB982188Q41646454-114317AA-028C-475E-A951-7B782564F8FAQ44172769-A8598DB0-74F8-4BEE-B2E1-147768F4631CQ46790139-23957619-4FB4-4CEA-9538-7F13BDB6CC18Q54205022-4B807803-A9A9-47DD-A12A-4709BD7EDBA1Q58571995-95AC31E1-64FD-4DE7-9D74-7116EDC61D67Q58796769-9AB989FC-3544-4AD2-900D-06E2E966A092
P2860
The role of regulated clinical trials in the development of bacteriophage therapeutics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The role of regulated clinical trials in the development of bacteriophage therapeutics.
@ast
The role of regulated clinical trials in the development of bacteriophage therapeutics.
@en
type
label
The role of regulated clinical trials in the development of bacteriophage therapeutics.
@ast
The role of regulated clinical trials in the development of bacteriophage therapeutics.
@en
prefLabel
The role of regulated clinical trials in the development of bacteriophage therapeutics.
@ast
The role of regulated clinical trials in the development of bacteriophage therapeutics.
@en
P2093
P2860
P1476
The role of regulated clinical trials in the development of bacteriophage therapeutics.
@en
P2093
Ben H Burrowes
David R Harper
Helena Mrt Parracho
Malcolm L McConville
P2860
P304
P356
10.4172/1747-0862.1000050
P50
P577
2012-04-23T00:00:00Z